Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Medicine
87 active people
651 grants
Recent Grants
Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
2024
·
$3.1M
neuroscience,
sleep,
transcranial stimulation,
brain stimulation,
default mode network
A Phase 3, Randomized, Open-label Study of MK-5684 versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed O
2024
·
$2.2M
prostate cancer,
clinical trial,
treatment comparison,
metastatic cancer,
hormone therapy
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
2024
·
$1.6M
cancer,
pharmacokinetics,
drug therapy,
clinical trial,
tumor treatment
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have
2024
·
$964K
clinical trials,
dermatology,
immunology,
inflammatory diseases,
pharmacology
Addressing Diet-Induced Health Disparities with Precision Nutrition and Omega-3 Fatty Acids
2024
·
$808.3K
nutrition,
health disparities,
precision nutrition,
omega-3 fatty acids
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors
2024
·
$724K
cancer,
immunotherapy,
clinical trial,
monotherapy,
combination therapy
Training in Environmental Toxicology of Human Disease
2024
·
$671.6K
environmental toxicology,
human disease,
training,
environmental health,
medical education
A Phase 1 Study With ABBV-CLS-484 Alone And In Combination In Subjects With Locally Advanced or Metastatic Tumors
2024
·
$635K
oncology,
clinical trial,
cancer treatment,
drug development,
immunotherapy
A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREG) in Patients with Locally Advanced (Inoperable) or Metastatic Renal Cell Carcinoma
2024
·
$625.4K
oncology,
clinical trial,
drug combination,
efficacy,
patient safety
Defining Mechanisms Of Cc16 On Epithelial-driven Host Responses To Pathogens
2024
·
$606.4K
lung inflammation,
host-pathogen interaction,
epithelial cells,
immune response,
biomarker
Phase 1 Trial Evaluating the Safety and Tolerability of Gamma Delta T-Cell Infusions in Combination with Low Dose Radiotherapy in Subjects with Stage 4 Metastatic Non-Small Cell Lung Cancer
2024
·
$577.4K
immunotherapy,
radiotherapy,
cancer,
clinical trial,
metastatic
A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hyp
2024
·
$555.7K
clinical trials,
pulmonary arterial hypertension,
drug efficacy,
safety evaluation,
combination treatment
Sunray-01, A Global Pivotal Study In Participants With Kras G12c-mutant, Locally Advanced, Or Metastatic Non-small Cell Lung Cancer Comparing First-line Treatment Of Ly3537982 And Pembrolizumab Vs Pla
2024
·
$554.9K
lung cancer,
targeted therapy,
immunotherapy,
clinical trial,
precision medicine
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Tre
2024
·
$548.6K
oncology,
clinical trials,
chemotherapy,
cancer treatment,
targeted therapy
Brightline-2: A Phase IIa/IIb, Open-label, Single-arm, Multi-centre Trial of BI 907828 for Treatment of Patients With Locally Advanced / Metastatic, MDM2 Amplified, TP53 Wild-type Biliary Track Adenoc
2024
·
$462K
cancer treatment,
clinical trial,
biliary tract adenocarcinoma,
targeted therapy,
precision medicine
A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator's Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/
2024
·
$434.6K
clinical trials,
cancer treatment,
monotherapy
A Phase 1/2 Open-Label, Multicenter, Global Trial to Characterize the Safety, Tolerability and Preliminary Efficacy of CFT1946 as a Monotherapy and in Combination with Trametinib in Subjects with BRAF
2024
·
$433.9K
drug development,
oncology,
clinical trials,
pharmacology,
precision medicine
Osseosurface Electronics: Chronic Wireless Battery Interfaces for Osteoporosis Treatment and Discovery
2024
·
$428.4K
biomedical engineering,
medical devices,
osteoporosis,
wireless technology,
electrical engineering
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
2024
·
$359.6K
sleep disturbances,
interventions,
sars-cov-2,
evaluation,
platform protocol
Computational Tools for Predicting and Understanding Knee Pain Spatial Patterns
2024
·
$348.7K
knee pain,
spatial patterns,
predicting,
understanding
People
Alyssa Guido
Community Outreach Manager III
Lise Alschuler
Assistant Director
Amy Sussman
Professor
Andrea Verdin
Research Program Administration Manager II
Bujji Ainapurapu
Associate Clinical Professor
Bhaskar Banerjee
Professor
Bekir Tanriover
Professor
Clara Curiel
Professor
Christian Bime
Associate Professor
Cathleen Wilson
Clinical Research Coordinator II
Ann Marie Chiasson
Director
Christopher Morton
Clinical Research Manager II
Elizabeth Connick
Professor
Connie Chan
Senior Clinical Pharmacist
Dawn Coletta
Associate Professor
Daniel Butler
Associate Professor
Deb Gilmore
Research Program Administration Officer III
Lin Ding
Researcher/Scientist III
Waleed Elhelaly
Instructor / Research Scholar
Erika Bracamonte
Professor
Fariba Donovan
Associate Professor
Frank Brosius
Professor
Joy Folkvord
Researcher/Scientist IV
Edward Gelmann
Professor
Heidi Erickson
Clinical Research Manager III
Joseph Alpert
Professor
Jennifer Carew
Professor
Joshua Farr
Associate Professor
Janet Funk
Professor
James Liao
Chair
Joao Albuquerque Ferreira
Assistant Clinical Professor
Jennifer Stern
Assistant Professor
Jose Elizondo
Research Program Administration Officer III
Julia Indik
Professor
James Knepler
Professor
Joshua Malo
Associate Professor
Juanita Merchant
Professor
Kristen Ellis
Clinical Pharmacist
Kristina Waters
Academic Programs Officer III
Keliegh Culpepper
Assistant Clinical Professor
C. Kent Kwoh
Professor
Paul Langlais
Associate Professor
Larry York
Pharmacist III
Luz Badilla
Clinical Research Coordinator II
Linda Garland
Professor
Laura Meinke
Associate Professor
Linda Phillips
Professor
Luke Szweda
Professor
Leah Stauber
Scientific Analyst II
Kevin Lohenry
Dean
Mathew Hutchinson
Professor, Medicine - (Clinical Scholar Track)
Lawrence Mandarino
Professor
Martha Barron
Research Program Administration Officer III
Matthew Hufford
Clinical Research Coordinator I
Moulun Luo
Associate Research Professor
Natalie Provencio Dean
Clinical Research Coordinator IV
Peter Ott
Associate Professor, Medicine - (Clinical Scholar Track)
Palash Mallick
Clinical Research Coordinator IV
Randy Horwitz
Medical Director
Adam Dean
Computing Sciences Researcher II
Richard De Armond
Laboratory Coordinator III
Franz Rischard
Professor
Rachna Shroff
Professor
HESHAM SADEK
Professor
Salma Patel
Assistant Professor
Suzann Duan
Assistant Research Professor
Nikola Sladojevic
Assistant Research Professor
Sicily La Rue
Clinical Research Coordinator IV
Stephen Klotz
Professor
Marvin Slepian
Professor
Steffan Nawrocki
Professor
Ricky Sontz
Research Specialist
John Galgiani
Director
Saad Sammani
Associate Research Professor
Sairam Parthasarathy
Professor
Stuart Quan
Professor Emeritus
Sasha Taleban
Associate Professor
Sulaiman Sheriff
Researcher/Scientist IV
Stefano Guerra
Research Scientist
Tara Tassin
Instructor / Research Scholar
Tara Carr
Professor
Trina Hughes
Clinical Research Coordinator III
Tejo Vemulapalli
Associate Clinical Professor
Tirdad Zangeneh
Professor
Vivian Kominos
Assistant Clinical Professor
Kavitha Yaddanapudi
Professor
Xiaoguang Sun
Associate Research Professor
Research expenses history
Funding support
15 funding agencies since 2020
